naltrexone and Drug Overdose

naltrexone has been researched along with Drug Overdose in 72 studies

Research

Studies (72)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	7 (9.72)	18.2507
2000's	19 (26.39)	29.6817
2010's	31 (43.06)	24.3611
2020's	15 (20.83)	2.80

Authors

Authors	Studies
Dasgupta, N; Saucier, R; Wolfe, D	1
Laks, J; Peterkin, A; Weinstein, ZM	1
Biondi, BE; Schlossberg, EF; Shaw, A; Springer, SA; Vander Wyk, B	1
Blanco, C; Compton, WM; Hodges, K; Jones, CM; Ling, SM; Losby, JL; Shoff, C	1
Balise, RR; Brandt, L; Castillo, F; Feaster, DJ; Hu, MC; Liu, Y; Luo, SX; Nunes, EV; Odom, GJ	1
Batty, E; Booty, M; Eddens, K; Knudsen, HK; Oser, CB; Perry, B; Rockett, M; Staton, M	1
Rodriguez, CP; Suzuki, J	1
Chatterjee, A; Linas, BP; Macmadu, A; Madushani, RWMA; Murphy, SM; Potee, RA; Ryan, D; Savinkina, A; Walley, AY; Weitz, M	1
Lin, MP; Manini, AF; Richardson, LD; Shastry, S	1
Bagley, SM; Bernson, D; Hadland, SE; Land, T; Larochelle, MR; Patel, A; Samet, JH; Silverstein, M; Walley, AY; Wang, N; Xuan, Z	1
Boss, R; Buchanan, AL; Coderre, T; Goedel, WC; Krieger, MS; Lebeau, R; Marshall, BDL; Paull, K; Rich, JD; Thompson, C; Yedinak, JL	1
Altomare, J; Bahji, A; Carlone, D	1
Agus, D; Fingerhood, M; Krawczyk, N; Lyons, BC; Mojtabai, R; Saloner, B; Stuart, EA; Weiner, JP	1
Babakhanlou-Chase, H; Bernson, D; Land, T; Larochelle, MR; Li, Y; Lodi, S; Walley, AY	1
Dionne, R; Fishman, M; Lertch, E; Ludwig, A; Mitchell, SG; Monico, LB; Schwartz, RP	1
Bhat, NR; Bierut, LJ; Borodovsky, JT; Grucza, RA; Mintz, CM; Presnall, N; Xu, KY	1
Alexander, E; Johnson, BD; Lincoln, T; McCarthy, P	1
Hulse, G; Kelty, E	1
Bigelow, GE; Holtyn, AF; Jarvis, BP; Oga, EA; Silverman, K; Subramaniam, S; Tompkins, DA	1
Alexander-Scott, N; Boss, R; Brinkley-Rubinstein, L; Clarke, J; Green, TC; Marshall, BDL; Rich, JD	1
Brinkley-Rubinstein, L; Cloud, DH; Heise, A; Martino, S; McCauley, E; Seal, D; Zaller, N	1
Quaye, AN; Ward, EN; Wilens, TE	1
Bisaga, A; Campbell, AN; Crystal, S; Friedmann, PD; Johnson, KA; Levin, FR; Nunes, EV; Olfson, M; Pincus, HA; Remien, RH; Williams, AR	1
Bagley, SM; Bernson, D; Land, T; Larochelle, MR; Liebschutz, JM; Stopka, TJ; Walley, AY; Wang, N; Xuan, Z	1
Bao, YP; Blow, FC; Degenhardt, L; Farrell, M; Ilgen, M; Li, JQ; Liu, MX; Lu, L; Ma, J; Shi, J; Su, MF; Wang, RJ	1
Alexander, GC; Saloner, B; Stoller, KB	1
Binswanger, IA; Fazel, S; Hellner, C; Larsson, H; Molero, Y; Zetterqvist, J	1
Binswanger, IA; Glanz, JM	1
Barry, CL; Mauro, C; Mojtabai, R; Olfson, M; Wall, MM	1
Chiang, CN; Crystal, R; Gyaw, S; Krieter, P; Skolnick, P	1
Babu, K; Bradley, ES; Brush, DE; Carreiro, SP; Liss, D	1
Barry, CL; Landis, R; Saloner, B; Stein, BD	1
Crystal, R; Gyaw, S; Krieter, P; Skolnick, P	1
Linas, BP; Morgan, JR; Schackman, BR; Walley, AY; Weinstein, ZM	1
Darke, S; Duflou, J; Farrell, M; Lappin, J; Larance, B	1
Kunøe, N; Stavseth, LS; Tanum, L	1
Dolgin, E	1
Boney, TY; Bonnie, RJ; Chen, DT; Cornish, JW; Fishman, M; Friedmann, PD; Gordon, M; Gourevitch, MN; Hoskinson, RA; Kinlock, TW; Lee, JD; McDonald, R; Murphy, SM; Nunes, EV; O'Brien, CP; Rotrosen, J; Wilson, D	1
Bonilla, W; Flannery, M; Goldfeld, K; Gourevitch, MN; Johnson, CW; Laska, E; Lee, JD; Leibowitz, N; McDonald, RD; Rotrosen, J; Santana-Correa, N; Tofighi, B	1
Barnett, G; Bruner, A; Fishman, M; Sharma, B	1
Gossop, M; Hegstad, S; Hjerkinn, B; Kristensen, Ø; Kunøe, N; Lobmaier, P; Vederhus, JK; Waal, H	1
Brosnan, RJ; Ilkiw, JE; Pypendop, BH	1
Costantino, CM; Devi, LA; Gomes, I; Lim, MP; Stockton, SD	1
Reece, AS	1
Bannwarth, B	1
Hulse, GK; Tait, RJ	2
Arnold-Reed, DE; Basso, MR; Hansson, RC; Holman, CD; Hulse, GK; Murray, SD; O'Neil, G	1
Digiusto, E; Mattick, RP; O'Brien, S; Ritter, A; Shakeshaft, A	1
Horspool, M; Keen, J; Oliver, P	1
Arnold-Reed, D; Comer, SD; Hulse, GK; Jacobs, IG; Sullivan, MA; Tait, RJ	1
Carai, MA; Colombo, G; Gessa, GL	1
Degenhardt, LJ; Gibson, AE; Hall, WD	1
Sim, MG	1
Batey, RG	1
Brewer, CL	1
Choy, W; Khong, E	1
Kunøe, N; Waal, H	1
Hulse, GK; Ngo, HT; Tait, RJ	1
Kaplan, JL; Marx, JA	1
Berg, BJ; Pettinati, HM; Volpicelli, JR	1
Chumpa, A	1
Calabro, JJ; Gaddis, GM; Gin-Shaw, SL; Harchelroad, FP; Kaplan, JL; Marx, JA; Spiller, JD; Spivey, WL; Zhao, N	1
Irvine, RJ; White, JM	1
Farrell, M; Keaney, F	1
Burakov, AM; Didenko, TY; Krupitsky, EM; Masalov, DV; Romanova, TN; Woody, G; Zvartau, EE	1
Appu, S; Thompson, G	1
Dhopesh, V; Fudala, PJ; Yu, E	1
Ritter, AJ	1

Reviews

16 review(s) available for naltrexone and Drug Overdose

Article	Year
Current Best Practices for Acute and Chronic Management of Patients with Opioid Use Disorder. The Medical clinics of North America, 2022, Volume: 106, Issue:1 Topics: Adult; Analgesics, Opioid; Buprenorphine; Comorbidity; Disease Management; Drug Overdose; Female; Fentanyl; Harm Reduction; Humans; Male; Mental Disorders; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Practice Guidelines as Topic; Prevalence	2022
Acceptability and efficacy of naltrexone for criminal justice-involved individuals with opioid use disorder: a systematic review and meta-analysis. Addiction (Abingdon, England), 2020, Volume: 115, Issue:8 Topics: Adult; Criminals; Delayed-Action Preparations; Drug Overdose; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Recurrence; Secondary Prevention; Treatment Outcome	2020
Extended-release injectable naltrexone for opioid use disorder: a systematic review. Addiction (Abingdon, England), 2018, Volume: 113, Issue:7 Topics: Analgesics, Opioid; Delayed-Action Preparations; Drug Overdose; Humans; Injections, Intramuscular; Medication Adherence; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Treatment Outcome	2018
Opioid Use Disorders: Perioperative Management of a Special Population. Anesthesia and analgesia, 2018, Volume: 127, Issue:2 Topics: Analgesics, Opioid; Buprenorphine; Drug Overdose; Drug Tolerance; Humans; Interdisciplinary Communication; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Pain Management; Patient Discharge; Patient-Centered Care; Perioperative Care	2018
Developing an opioid use disorder treatment cascade: A review of quality measures. Journal of substance abuse treatment, 2018, Volume: 91 Topics: Analgesics, Opioid; Buprenorphine; Drug Overdose; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Treatment Outcome	2018
Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis. Molecular psychiatry, 2019, Volume: 24, Issue:12 Topics: Adult; Analgesics, Opioid; Buprenorphine; Cohort Studies; Drug Overdose; Female; Humans; Male; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Risk	2019
Potential uses of naltrexone in emergency department patients with opioid use disorder. Clinical toxicology (Philadelphia, Pa.), 2019, Volume: 57, Issue:9 Topics: Analgesics, Opioid; Drug Overdose; Emergency Service, Hospital; Humans; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders	2019
Opioid Use Disorders. Child and adolescent psychiatric clinics of North America, 2016, Volume: 25, Issue:3 Topics: Adolescent; Analgesics, Opioid; Buprenorphine; Drug Overdose; Humans; Naloxone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders	2016
Opioid receptor heteromers in analgesia. Expert reviews in molecular medicine, 2012, Apr-10, Volume: 14 Topics: Analgesia; Analgesics; Animals; Drug Antagonism; Drug Overdose; Humans; Morphine Dependence; Naloxone; Naltrexone; Narcotic Antagonists; Pain; Protein Multimerization; Protein Structure, Quaternary; Receptors, Opioid, delta; Receptors, Opioid, mu; Signal Transduction; United States	2012
Clinical safety of 1500 mg oral naltrexone overdose. BMJ case reports, 2010, Sep-07, Volume: 2010 Topics: Administration, Oral; Adult; Alcoholism; Behavior, Addictive; Dose-Response Relationship, Drug; Drug Overdose; Female; Follow-Up Studies; Humans; Maximum Tolerated Dose; Naltrexone; Narcotic Antagonists; Patient Safety; Risk Assessment; Substance-Related Disorders	2010
Will abuse-deterrent formulations of opioid analgesics be successful in achieving their purpose? Drugs, 2012, Sep-10, Volume: 72, Issue:13 Topics: Analgesics, Opioid; Chemistry, Pharmaceutical; Drug Combinations; Drug Discovery; Drug Overdose; Drug Prescriptions; Humans; Morphine; Naltrexone; Opioid-Related Disorders; Pain	2012
A risk-benefit assessment of naltrexone in the treatment of alcohol dependence. Drug safety, 1996, Volume: 15, Issue:4 Topics: Alcoholism; Dose-Response Relationship, Drug; Drug Interactions; Drug Overdose; Humans; Liver; Naltrexone; Narcotic Antagonists; Neurosecretory Systems; Risk Assessment; Substance-Related Disorders	1996
Nalmefene hydrochloride. Pediatric emergency care, 1999, Volume: 15, Issue:2 Topics: Clinical Trials as Topic; Drug Overdose; Half-Life; Humans; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics	1999
Mechanisms of fatal opioid overdose. Addiction (Abingdon, England), 1999, Volume: 94, Issue:7 Topics: Drug Interactions; Drug Overdose; Drug Tolerance; Humans; Naltrexone; Narcotics; Neurotransmitter Agents; Opioid-Related Disorders; Respiration; Respiratory Insufficiency	1999
Safe approaches to treating drug addiction. The Practitioner, 2000, Volume: 244, Issue:1610 Topics: Drug Overdose; Family Practice; Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Sorption Detoxification; Substance-Related Disorders	2000
Naltrexone in the treatment of heroin dependence: relationship with depression and risk of overdose. The Australian and New Zealand journal of psychiatry, 2002, Volume: 36, Issue:2 Topics: Depressive Disorder; Drug Overdose; Heroin Dependence; Humans; Naltrexone; Narcotic Antagonists; Risk Factors	2002

Trials

8 trial(s) available for naltrexone and Drug Overdose

Article	Year
Opioid overdose experiences in a sample of US adolescents and young adults: a thematic analysis. Addiction (Abingdon, England), 2021, Volume: 116, Issue:4 Topics: Adolescent; Analgesics, Opioid; Drug Overdose; Humans; Naltrexone; Narcotic Antagonists; Opiate Overdose; Opioid-Related Disorders; United States; Young Adult	2021
Fighting Fire with Fire: Development of Intranasal Nalmefene to Treat Synthetic Opioid Overdose. The Journal of pharmacology and experimental therapeutics, 2019, Volume: 371, Issue:2 Topics: Administration, Intranasal; Adolescent; Adult; Analgesics, Opioid; Cross-Over Studies; Double-Blind Method; Drug Development; Drug Overdose; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Synthetic Drugs; Treatment Outcome; Young Adult	2019
Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders. The New England journal of medicine, 2016, Mar-31, Volume: 374, Issue:13 Topics: Adult; Community Health Services; Counseling; Criminals; Delayed-Action Preparations; Drug Overdose; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Secondary Prevention; Substance Abuse, Intravenous	2016
Extended-release naltrexone opioid treatment at jail reentry (XOR). Contemporary clinical trials, 2016, Volume: 49 Topics: Analgesics, Opioid; Cause of Death; Delayed-Action Preparations; Drug Overdose; Humans; Injections, Intramuscular; Methadone; Mortality; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Participation; Prisons; Secondary Prevention	2016
Challenges to antagonist blockade during sustained-release naltrexone treatment. Addiction (Abingdon, England), 2010, Volume: 105, Issue:9 Topics: Adult; Crime; Delayed-Action Preparations; Depression; Drug Implants; Drug Overdose; Euphoria; Female; Hair; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Patient Compliance; Psychiatric Status Rating Scales; Secondary Prevention; Substance Abuse Detection; Substance Withdrawal Syndrome; Treatment Outcome; Young Adult	2010
Use of naltrexone to antagonize high doses of remifentanil in cats: a dose-finding study. Veterinary anaesthesia and analgesia, 2011, Volume: 38, Issue:6 Topics: Analgesics, Opioid; Animals; Cat Diseases; Cats; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Overdose; Female; Hyperkinesis; Naltrexone; Narcotic Antagonists; Piperidines; Prospective Studies; Remifentanil	2011
Effectiveness and safety of intravenous nalmefene for emergency department patients with suspected narcotic overdose: a pilot study. Annals of emergency medicine, 1993, Volume: 22, Issue:2 Topics: Adolescent; Adult; Drug Overdose; Emergency Service, Hospital; Female; Humans; Injections, Intravenous; Male; Naltrexone; Narcotic Antagonists; Narcotics; Pilot Projects; Prospective Studies; Treatment Outcome	1993
Double-blind, randomized study of nalmefene and naloxone in emergency department patients with suspected narcotic overdose. Annals of emergency medicine, 1999, Volume: 34, Issue:1 Topics: Adult; Double-Blind Method; Drug Overdose; Emergency Treatment; Humans; Injections, Intravenous; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Neurologic Examination; Respiration; Time Factors; Treatment Outcome	1999

Other Studies

48 other study(ies) available for naltrexone and Drug Overdose

Article	Year
Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence. Drug safety, 2018, Volume: 41, Issue:10 Topics: Adult; Cause of Death; Delayed-Action Preparations; Drug Overdose; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Retrospective Studies; Time Factors; Young Adult	2018
Factors associated with retention on medications for opioid use disorder among a cohort of adults seeking treatment in the community. Addiction science & clinical practice, 2022, 03-07, Volume: 17, Issue:1 Topics: Adult; Analgesics, Opioid; Buprenorphine; Drug Overdose; Female; Humans; Male; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Pain; Prospective Studies	2022
Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic. JAMA psychiatry, 2022, 10-01, Volume: 79, Issue:10 Topics: Aged; Analgesics, Opioid; Buprenorphine; COVID-19; Drug Overdose; Female; Humans; Longitudinal Studies; Male; Medicare; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Pandemics; Telemedicine; United States	2022
Risk of Experiencing an Overdose Event for Patients Undergoing Treatment With Medication for Opioid Use Disorder. The American journal of psychiatry, 2023, 05-01, Volume: 180, Issue:5 Topics: Buprenorphine; Drug Overdose; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders	2023
Social ecological factors and medication treatment for opioid use disorder among justice-involved rural and urban persons: the BMJ open, 2023, 03-20, Volume: 13, Issue:3 Topics: Analgesics, Opioid; Buprenorphine; Delayed-Action Preparations; Drug Overdose; Humans; Longitudinal Studies; Naltrexone; Narcotic Antagonists; Observational Studies as Topic; Opioid-Related Disorders; Recurrence; Reproducibility of Results	2023
Case series: Voluntary discontinuation of sublingual buprenorphine treatment for opioid use disorder using extended-release buprenorphine. The American journal on addictions, 2023, Volume: 32, Issue:3 Topics: Administration, Sublingual; Analgesics, Opioid; Buprenorphine; Delayed-Action Preparations; Drug Overdose; Humans; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders	2023
Estimated Costs and Outcomes Associated With Use and Nonuse of Medications for Opioid Use Disorder During Incarceration and at Release in Massachusetts. JAMA network open, 2023, 04-03, Volume: 6, Issue:4 Topics: Analgesics, Opioid; Buprenorphine; Drug Overdose; Humans; Massachusetts; Naltrexone; Opioid-Related Disorders	2023
Nalmefene nasal spray (Opvee) for reversal of opioid overdose. The Medical letter on drugs and therapeutics, 2023, 10-16, Volume: 65, Issue:1687 Topics: Analgesics, Opioid; Drug Overdose; Humans; Naloxone; Naltrexone; Narcotic Antagonists; Nasal Sprays; Opiate Overdose	2023
US ED Opioid-Related Visits Increase, While Use of Medication for Opioid Use Disorder Undetectable, 2011-2016. Journal of general internal medicine, 2020, Volume: 35, Issue:3 Topics: Buprenorphine; Drug Overdose; Emergency Service, Hospital; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Practice Patterns, Physicians'; Retrospective Studies; United States	2020
Characteristics and Receipt of Medication Treatment Among Young Adults Who Experience a Nonfatal Opioid-Related Overdose. Annals of emergency medicine, 2020, Volume: 75, Issue:1 Topics: Adolescent; Adult; Age Distribution; Analgesics, Opioid; Buprenorphine; Databases, Factual; Drug Overdose; Female; Humans; Male; Massachusetts; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Proportional Hazards Models; Retrospective Studies; Time-to-Treatment; Young Adult	2020
Defining a recovery-oriented cascade of care for opioid use disorder: A community-driven, statewide cross-sectional assessment. PLoS medicine, 2019, Volume: 16, Issue:11 Topics: Analgesics, Opioid; Clinical Protocols; Cross-Sectional Studies; Drug Overdose; Humans; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Rhode Island; Risk Assessment; Risk Factors; Social Work; Stakeholder Participation; Substance-Related Disorders; United States	2019
Opioid agonist treatment and fatal overdose risk in a state-wide US population receiving opioid use disorder services. Addiction (Abingdon, England), 2020, Volume: 115, Issue:9 Topics: Adolescent; Adult; Analgesics, Opioid; Buprenorphine; Cause of Death; Cohort Studies; Drug Overdose; Female; Humans; Male; Maryland; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Proportional Hazards Models; Retrospective Studies; Time Factors; United States; Young Adult	2020
Association between mortality rates and medication and residential treatment after in-patient medically managed opioid withdrawal: a cohort analysis. Addiction (Abingdon, England), 2020, Volume: 115, Issue:8 Topics: Adolescent; Adult; Buprenorphine; Cohort Studies; Drug Overdose; Female; Humans; Male; Massachusetts; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Proportional Hazards Models; Residential Treatment; Retrospective Studies; Substance Withdrawal Syndrome; Young Adult	2020
Association of Opioid Use Disorder Treatment With Alcohol-Related Acute Events. JAMA network open, 2021, 02-01, Volume: 4, Issue:2 Topics: Accidental Falls; Adult; Alcohol-Related Disorders; Alcoholism; Analgesics, Opioid; Buprenorphine; Central Nervous System Depressants; Drug Overdose; Ethanol; Female; Humans; Male; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Protective Factors; Wounds and Injuries; Young Adult	2021
Extended-release naltrexone for opioid use disorder started during or following incarceration. Journal of substance abuse treatment, 2018, Volume: 85 Topics: Adult; Ambulatory Care; Delayed-Action Preparations; Drug Overdose; Female; Humans; Injections, Intramuscular; Male; Massachusetts; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Prisons; Prospective Studies	2018
Fatal and non-fatal opioid overdose in opioid dependent patients treated with methadone, buprenorphine or implant naltrexone. The International journal on drug policy, 2017, Volume: 46 Topics: Adult; Buprenorphine; Cohort Studies; Drug Implants; Drug Overdose; Female; Humans; Male; Methadone; Multivariate Analysis; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Proportional Hazards Models; Prospective Studies; Retrospective Studies; Risk Factors; Western Australia; Young Adult	2017
Postincarceration Fatal Overdoses After Implementing Medications for Addiction Treatment in a Statewide Correctional System. JAMA psychiatry, 2018, 04-01, Volume: 75, Issue:4 Topics: Adolescent; Adult; Buprenorphine; Cause of Death; Drug Overdose; Female; Fentanyl; Health Plan Implementation; Humans; Male; Methadone; Middle Aged; Naltrexone; Odds Ratio; Opioid-Related Disorders; Patient Discharge; Prisoners; Prisons; Retrospective Studies; Rhode Island; Transitional Care; Young Adult	2018
Criminal justice continuum for opioid users at risk of overdose. Addictive behaviors, 2018, Volume: 86 Topics: Analgesics, Opioid; Criminal Law; Delayed-Action Preparations; Drug Overdose; Humans; Judicial Role; Law Enforcement; Mass Screening; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Prisons; Risk Assessment; United States	2018
Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality: A Cohort Study. Annals of internal medicine, 2018, 08-07, Volume: 169, Issue:3 Topics: Adolescent; Adult; Analgesics, Opioid; Buprenorphine; Drug Overdose; Female; Humans; Male; Massachusetts; Methadone; Middle Aged; Mortality; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Proportional Hazards Models; Retrospective Studies; Young Adult	2018
Moving Addiction Care to the Mainstream - Improving the Quality of Buprenorphine Treatment. The New England journal of medicine, 2018, Jul-05, Volume: 379, Issue:1 Topics: Buprenorphine; Drug Approval; Drug Overdose; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Primary Health Care; United States; United States Food and Drug Administration	2018
Medications for Alcohol and Opioid Use Disorders and Risk of Suicidal Behavior, Accidental Overdoses, and Crime. The American journal of psychiatry, 2018, 10-01, Volume: 175, Issue:10 Topics: Acamprosate; Adult; Aged; Alcohol Deterrents; Alcoholism; Buprenorphine; Cohort Studies; Crime; Drug Overdose; Female; Follow-Up Studies; Humans; Male; Methadone; Middle Aged; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Risk Factors; Suicidal Ideation; Young Adult	2018
Potential Risk Window for Opioid Overdose Related to Treatment with Extended-Release Injectable Naltrexone. Drug safety, 2018, Volume: 41, Issue:10 Topics: Analgesics, Opioid; Delayed-Action Preparations; Drug Overdose; Humans; Naltrexone; Opioid-Related Disorders	2018
Medication Treatment For Opioid Use Disorders In Substance Use Treatment Facilities. Health affairs (Project Hope), 2019, Volume: 38, Issue:1 Topics: Buprenorphine; Drug Overdose; Health Services Accessibility; Humans; Insurance, Health; Medicaid; Medicare; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Substance Abuse Treatment Centers; United States	2019
Enhanced Intranasal Absorption of Naltrexone by Dodecyl Maltopyranoside: Implications for the Treatment of Opioid Overdose. Journal of clinical pharmacology, 2019, Volume: 59, Issue:7 Topics: Administration, Intranasal; Administration, Oral; Adult; Area Under Curve; Cell Line; Cross-Over Studies; Drug Overdose; Female; Half-Life; Humans; Hydrogen-Ion Concentration; Injections, Intramuscular; Male; Maltose; Middle Aged; Naltrexone; Nasal Absorption; Opiate Alkaloids; Permeability; Young Adult	2019
The Affordable Care Act In The Heart Of The Opioid Crisis: Evidence From West Virginia. Health affairs (Project Hope), 2019, Volume: 38, Issue:4 Topics: Buprenorphine; Databases, Factual; Drug Overdose; Female; Humans; Insurance Claim Review; Male; Medicaid; Naltrexone; Narcotic Antagonists; Opioid Epidemic; Opioid-Related Disorders; Patient Protection and Affordable Care Act; Prevalence; Retrospective Studies; Risk Assessment; Survival Analysis; United States; West Virginia	2019
Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort. Drug and alcohol dependence, 2019, 07-01, Volume: 200 Topics: Adult; Buprenorphine; Cohort Studies; Delayed-Action Preparations; Drug Overdose; Female; Follow-Up Studies; Humans; Insurance, Health; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Retrospective Studies; United States; Young Adult	2019
Circumstances of death of opioid users being treated with naltrexone. Addiction (Abingdon, England), 2019, Volume: 114, Issue:11 Topics: Administration, Oral; Adolescent; Adult; Analgesics, Opioid; Australia; Cause of Death; Drug Implants; Drug Overdose; Female; Humans; Male; Medication Adherence; Middle Aged; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Suicide; Young Adult	2019
[Long-acting naltrexone--a new way out of opiate addiction?]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2013, Nov-12, Volume: 133, Issue:21 Topics: Delayed-Action Preparations; Drug Overdose; Humans; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders	2013
Technology: Barriers to misuse. Nature, 2015, Jun-25, Volume: 522, Issue:7557 Topics: Analgesics, Opioid; Chemistry, Pharmaceutical; Drug Combinations; Drug Overdose; Drug Users; Humans; Morphine; Naltrexone; Opioid-Related Disorders; Oxycodone; Prodrugs	2015
A pilot study to assess the impact of naltrexone implant on accidental opiate overdose in 'high-risk' adolescent heroin users. Addiction biology, 2003, Volume: 8, Issue:3 Topics: Accidents; Administration, Oral; Adolescent; Adolescent Behavior; Adult; Drug Overdose; Female; Follow-Up Studies; Heroin Dependence; Hospitalization; Humans; Infusion Pumps, Implantable; Male; Naltrexone; Narcotic Antagonists; Pilot Projects; Risk-Taking; Time Factors	2003
Blood morphine levels in naltrexone-exposed compared to non-naltrexone-exposed fatal heroin overdoses. Addiction biology, 2003, Volume: 8, Issue:3 Topics: Adult; Australia; Cohort Studies; Drug Overdose; Female; Heroin; Heroin Dependence; Humans; Male; Morphine; Naltrexone; Narcotic Antagonists; Registries; Retrospective Studies; Time Factors	2003
Serious adverse events in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD). Addiction (Abingdon, England), 2004, Volume: 99, Issue:4 Topics: Adult; Analgesics, Opioid; Australia; Buprenorphine; Drug Overdose; Female; Humans; Male; Methadone; Methadyl Acetate; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders	2004
Fatal opiate overdose following regimen changes in naltrexone treatment. Addiction (Abingdon, England), 2005, Volume: 100, Issue:4 Topics: Drug Implants; Drug Overdose; Fatal Outcome; Humans; Infusion Pumps, Implantable; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders	2005
Reducing hospital presentations for opioid overdose in patients treated with sustained release naltrexone implants. Drug and alcohol dependence, 2005, Sep-01, Volume: 79, Issue:3 Topics: Adult; Cohort Studies; Drug Implants; Drug Overdose; Emergency Service, Hospital; Female; Heroin Dependence; Hospitalization; Humans; Male; Medical Record Linkage; Naltrexone; Narcotics; Opioid-Related Disorders; Patient Admission; Prospective Studies	2005
Resuscitative effect of a gamma-aminobutyric acid B receptor antagonist on gamma-hydroxybutyric acid mortality in mice. Annals of emergency medicine, 2005, Volume: 45, Issue:6 Topics: Animals; Benzocycloheptenes; Bicuculline; Drug Overdose; Flumazenil; GABA Antagonists; gamma-Aminobutyric Acid; Male; Mice; Morpholines; Naltrexone; Neuroprotective Agents; Neurotransmitter Agents; Survival Rate; Taurine	2005
Opioid overdose deaths can occur in patients with naltrexone implants. The Medical journal of Australia, 2007, Feb-05, Volume: 186, Issue:3 Topics: Drug Implants; Drug Overdose; Drug Synergism; Fatal Outcome; Female; Humans; Male; Naltrexone; Narcotic Antagonists	2007
Opioid overdose deaths can occur in patients with naltrexone implants. The Medical journal of Australia, 2007, Jul-02, Volume: 187, Issue:1 Topics: Analgesics, Opioid; Drug Implants; Drug Overdose; Humans; Naltrexone; Narcotic Antagonists; Patient Selection	2007
Opioid overdose deaths can occur in patients with naltrexone implants. The Medical journal of Australia, 2007, Jul-02, Volume: 187, Issue:1 Topics: Analgesics, Opioid; Drug Implants; Drug Overdose; Heroin; Humans; Naltrexone; Narcotic Antagonists; Substance-Related Disorders	2007
Opioid overdose deaths can occur in patients with naltrexone implants. The Medical journal of Australia, 2007, Jul-02, Volume: 187, Issue:1 Topics: Analgesics, Opioid; Autopsy; Drug Implants; Drug Monitoring; Drug Overdose; Humans; Naltrexone; Narcotic Antagonists; Substance-Related Disorders	2007
Opioid overdose deaths can occur in patients with naltrexone implants. The Medical journal of Australia, 2007, Jul-02, Volume: 187, Issue:1 Topics: Analgesics, Opioid; Drug Implants; Drug Overdose; Humans; Naltrexone; Narcotic Antagonists; Substance-Related Disorders; Treatment Outcome	2007
Opioid overdose deaths can occur in patients with naltrexone implants. The Medical journal of Australia, 2007, Jul-02, Volume: 187, Issue:1 Topics: Analgesics, Opioid; Drug Implants; Drug Overdose; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Patient Selection; Substance-Related Disorders	2007
Opioid overdose deaths can occur in patients with naltrexone implants. The Medical journal of Australia, 2007, Jul-02, Volume: 187, Issue:1 Topics: Analgesics, Opioid; Cause of Death; Drug Implants; Drug Overdose; Humans; Naltrexone; Narcotic Antagonists; Substance-Related Disorders	2007
Mortality in heroin users 3 years after naltrexone implant or methadone maintenance treatment. Journal of substance abuse treatment, 2008, Volume: 35, Issue:2 Topics: Adult; Cohort Studies; Databases, Factual; Drug Implants; Drug Overdose; Female; Heroin Dependence; Humans; Male; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Suicide; Time Factors; Western Australia	2008
Nalmefene--a long-acting injectable opioid antagonist. The Medical letter on drugs and therapeutics, 1995, Oct-27, Volume: 37, Issue:960 Topics: Clinical Trials as Topic; Costs and Cost Analysis; Dose-Response Relationship, Drug; Drug Overdose; Humans; Injections, Intravenous; Kidney Failure, Chronic; Liver Diseases; Naltrexone; Narcotic Antagonists; Postoperative Care; Respiratory Insufficiency	1995
Nalmefene. JF 1, nalmetrene, NIH 10365, ORF 11676, Arthrene, Cervene, Incystene, Revex. Drugs in R&D, 1999, Volume: 1, Issue:1 Topics: Animals; Drug Overdose; Drugs, Investigational; Humans; Male; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Rabbits; Stroke	1999
Prevention of suicide by naltrexone in a recently detoxified heroin addict. European addiction research, 2001, Volume: 7, Issue:2 Topics: Adult; Drug Overdose; Heroin Dependence; Humans; Male; Naltrexone; Suicide Prevention; Time Factors	2001
Gangrenous ischaemic colitis following non-steroidal anti-inflammatory drug overdose. ANZ journal of surgery, 2001, Volume: 71, Issue:11 Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Butylscopolammonium Bromide; Colitis, Ischemic; Colon; Drug Overdose; Female; Humans; Ibuprofen; Naltrexone	2001
Conservative management with naltrexone of an iatrogenic methadone overdose in an opiate-naive patient. Journal of clinical psychopharmacology, 2002, Volume: 22, Issue:2 Topics: Alcoholism; Cocaine-Related Disorders; Diagnosis, Dual (Psychiatry); Drug Overdose; Humans; Male; Medication Errors; Methadone; Middle Aged; Naltrexone; Schizophrenia	2002